1189 related articles for article (PubMed ID: 10021453)
1. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
3. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
5. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
6. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
7. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
9. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
[TBL] [Abstract][Full Text] [Related]
10. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
11. Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus.
Cirillo N; Santoro R; Lanza M; Annese P; Gombos F; Lanza A
Clin Exp Dermatol; 2008 Jan; 33(1):32-5. PubMed ID: 17983457
[TBL] [Abstract][Full Text] [Related]
12. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
[TBL] [Abstract][Full Text] [Related]
13. Role of intramolecular epitope spreading in pemphigus vulgaris.
Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
[TBL] [Abstract][Full Text] [Related]
14. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
15. The desmosome and hemidesmosome in cutaneous autoimmunity.
Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
[TBL] [Abstract][Full Text] [Related]
16. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH
Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
[TBL] [Abstract][Full Text] [Related]
17. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1.
Shirakata Y; Amagai M; Hanakawa Y; Nishikawa T; Hashimoto K
J Invest Dermatol; 1998 Jan; 110(1):76-8. PubMed ID: 9424092
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
[TBL] [Abstract][Full Text] [Related]
19. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome.
Nagasaka T; Nishifuji K; Ota T; Whittock NV; Amagai M
J Clin Invest; 2004 Nov; 114(10):1484-92. PubMed ID: 15545999
[TBL] [Abstract][Full Text] [Related]
20. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
